Publications by authors named "Steven A Buck"

Claim this Profile
O
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress.
Jenna L Carter, Yongwei Su, Eman T Al-Antary, Jianlei Zhao, Xinan Qiao, Steven A Buck

J Exp Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia.
Jeffrey W Taub, Steven A Buck, Ana C Xavier, Holly Edwards, Larry H Matherly

Pediatr Blood Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.
Yongwei Su, Jenna L Carter, Xinyu Li, Yu Fukuda, Ashley Gray, Steven A Buck

Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Katie H Hurrish, Yongwei Su, Shraddha Patel, Cassandra L Ramage, Jianlei Zhao, Steven A Buck

Biochem Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Katie H Hurrish, Yongwei Su, Shraddha Patel, Cassandra L Ramage, Jenna L Carter, Steven A Buck

Res Sq· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia.
Daniel A Luedtke, Yongwei Su, Jun Ma, Xinyu Li, Steven A Buck

Signal Transduct Target Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for Increased Response to Induced Endoplasmic Reticulum Stress in Myeloid Cells in Acquired Aplastic Anemia.
Alpa Sidhu, Michael U Callaghan, Manisha S Gadgeel, Steven A Buck, Andrew M Fribley

J Pediatr Hematol Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous remission of congenital AML with skin involvement and t(1;11)(p32;q23).
Rohith Jesudas, Steven A Buck, Sureyya Savasan

Pediatr Blood Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting histone deacetylases (HDACs) and Wee1 for treating high-risk neuroblastoma.
Santosh S Hanmod, Guan Wang, Holly Edwards, Steven A Buck, Yubin Ge

Pediatr Blood Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.
J Timothy Caldwell, Holly Edwards, Steven A Buck, Yubin Ge, Jeffrey W Taub

Pediatr Blood Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.
Chengzhi Xie, Christina Drenberg, Holly Edwards, J Timothy Caldwell, Wei Chen, Steven A Buck

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells.
Guan Wang, Holly Edwards, J Timothy Caldwell, Steven A Buck, William Y Qing

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia.
John Timothy Caldwell, Holly Edwards, Alan A Dombkowski, Steven A Buck, Larry H Matherly

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.
Chengzhi Xie, Holly Edwards, Salvatore B Lograsso, Steven A Buck, Larry H Matherly

Pediatr Blood Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.
Sharada D Vangipuram, Steven A Buck, William D Lyman

Tumour Biol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Ana C Xavier, Holly Edwards, Alan A Dombkowski, Tugce B Balci, Jason N Berman, Steven A Buck

PLoS One· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric acute myeloid leukemia cells.
Xuelian Xu, Chengzhi Xie, Holly Edwards, Hui Zhou, Steven A Buck

PLoS One· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia.
Chengzhi Xie, Holly Edwards, Xuelian Xu, Hui Zhou, Steven A Buck

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.
Holly Edwards, Chengzhi Xie, Katherine M LaFiura, Alan A Dombkowski, Steven A Buck

Blood· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activity.
Yijun Deng, Yiqiang Wang, Christina Cherian, Zhanjun Hou, Steven A Buck

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
Yubin Ge, Alan A Dombkowski, Katherine M LaFiura, Dana Tatman, Ravikiran S Yedidi, Steven A Buck

Blood· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SELECTION FOR DELAYED SENESCENCE IN DROSOPHILA MELANOGASTER.
Leo S Luckinbill, Robert Arking, Michael J Clare, William C Cirocco, Steven A Buck

Evolution· September 1984

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis